157 related articles for article (PubMed ID: 35955415)
1. Dysregulation of SIRT3 SUMOylation Confers AML Chemoresistance via Controlling HES1-Dependent Fatty Acid Oxidation.
Zhang Y; Shen Y; Wei W; Wang W; Jiang D; Ren Y; Peng Z; Fan Q; Cheng J; Ma J
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955415
[TBL] [Abstract][Full Text] [Related]
2. SIRT3 deacetylase activity confers chemoresistance in AML via regulation of mitochondrial oxidative phosphorylation.
Ma J; Liu B; Yu D; Zuo Y; Cai R; Yang J; Cheng J
Br J Haematol; 2019 Oct; 187(1):49-64. PubMed ID: 31236919
[TBL] [Abstract][Full Text] [Related]
3. SENP1-Sirt3 Signaling Controls Mitochondrial Protein Acetylation and Metabolism.
Wang T; Cao Y; Zheng Q; Tu J; Zhou W; He J; Zhong J; Chen Y; Wang J; Cai R; Zuo Y; Wei B; Fan Q; Yang J; Wu Y; Yi J; Li D; Liu M; Wang C; Zhou A; Li Y; Wu X; Yang W; Chin YE; Chen G; Cheng J
Mol Cell; 2019 Aug; 75(4):823-834.e5. PubMed ID: 31302001
[TBL] [Abstract][Full Text] [Related]
4. Sirt3 promotes the autophagy of HK‑2 human proximal tubular epithelial cells via the inhibition of Notch‑1/Hes‑1 signaling.
Wang Y; Chang J; Wang ZQ; Li Y
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278469
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous inhibition of Sirtuin 3 and cholesterol homeostasis targets acute myeloid leukemia stem cells by perturbing fatty acid β-oxidation and inducing lipotoxicity.
O'Brien C; Ling T; Berman JM; Culp-Hill R; Reisz JA; Rondeau V; Jahangiri S; St-Germain J; Macwan V; Astori A; Zeng A; Hong JY; Li M; Yang M; Jana S; Gamboni F; Tsao E; Liu W; Dick JE; Lin H; Melnick A; Tikhonova A; Arruda A; Minden MD; Raught B; D'Alessandro A; Jones CL
Haematologica; 2023 Sep; 108(9):2343-2357. PubMed ID: 37021547
[TBL] [Abstract][Full Text] [Related]
6. Sirt3 modulates fatty acid oxidation and attenuates cisplatin-induced AKI in mice.
Li M; Li CM; Ye ZC; Huang J; Li Y; Lai W; Peng H; Lou TQ
J Cell Mol Med; 2020 May; 24(9):5109-5121. PubMed ID: 32281286
[TBL] [Abstract][Full Text] [Related]
7. N6-methyladenosine-modified SENP1, identified by IGF2BP3, is a novel molecular marker in acute myeloid leukemia and aggravates progression by activating AKT signal via de-SUMOylating HDAC2.
Wen D; Xiao H; Gao Y; Zeng H; Deng J
Mol Cancer; 2024 May; 23(1):116. PubMed ID: 38822351
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
[TBL] [Abstract][Full Text] [Related]
9. Nicotinamide mononucleotide attenuates airway epithelial barrier dysfunction via inhibiting SIRT3 SUMOylation in asthma.
Liang J; Zhou C; Zhang C; Liang S; Zhou Z; Zhou Z; Wu C; Zhao H; Meng X; Zou F; Yu C; Cai S
Int Immunopharmacol; 2024 Jan; 127():111328. PubMed ID: 38064810
[TBL] [Abstract][Full Text] [Related]
10. Targeting Myeloperoxidase Disrupts Mitochondrial Redox Balance and Overcomes Cytarabine Resistance in Human Acute Myeloid Leukemia.
Hosseini M; Rezvani HR; Aroua N; Bosc C; Farge T; Saland E; Guyonnet-Dupérat V; Zaghdoudi S; Jarrou L; Larrue C; Sabatier M; Mouchel PL; Gotanègre M; Piechaczyk M; Bossis G; Récher C; Sarry JE
Cancer Res; 2019 Oct; 79(20):5191-5203. PubMed ID: 31358527
[TBL] [Abstract][Full Text] [Related]
11. Glucose limitation activates AMPK coupled SENP1-Sirt3 signalling in mitochondria for T cell memory development.
He J; Shangguan X; Zhou W; Cao Y; Zheng Q; Tu J; Hu G; Liang Z; Jiang C; Deng L; Wang S; Yang W; Zuo Y; Ma J; Cai R; Chen Y; Fan Q; Dong B; Xue W; Tan H; Qi Y; Gu J; Su B; Eugene Chin Y; Chen G; Wang Q; Wang T; Cheng J
Nat Commun; 2021 Jul; 12(1):4371. PubMed ID: 34272364
[TBL] [Abstract][Full Text] [Related]
12. IL-6 promotes chemoresistance via upregulating CD36 mediated fatty acids uptake in acute myeloid leukemia.
Zhang Y; Guo H; Zhang Z; Lu W; Zhu J; Shi J
Exp Cell Res; 2022 Jun; 415(1):113112. PubMed ID: 35346671
[TBL] [Abstract][Full Text] [Related]
13. Coculture in vitro with endothelial cells induces cytarabine resistance of acute myeloid leukemia cells in a VEGF-A/VEGFR-2 signaling-independent manner.
Okamoto S; Miyano K; Kitakaze K; Kato H; Yamauchi A; Kajikawa M; Itsumi M; Kawai C; Kuribayashi F
Biochem Biophys Res Commun; 2022 Jan; 587():78-84. PubMed ID: 34872003
[TBL] [Abstract][Full Text] [Related]
14. Sirtuin 3 improves fatty acid metabolism in response to high nonesterified fatty acids in calf hepatocytes by modulating gene expression.
Liu L; Xing D; Du X; Peng T; McFadden JW; Wen L; Lei H; Dong W; Liu G; Wang Z; Su J; He J; Li X
J Dairy Sci; 2020 Jul; 103(7):6557-6568. PubMed ID: 32331890
[TBL] [Abstract][Full Text] [Related]
15. EAPB0503, an Imidazoquinoxaline Derivative Modulates SENP3/ARF Mediated SUMOylation, and Induces NPM1c Degradation in NPM1 Mutant AML.
Skayneh H; Jishi B; Hleihel R; Hamie M; El Hajj R; Deleuze-Masquefa C; Bonnet PA; El Sabban M; El Hajj H
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408798
[TBL] [Abstract][Full Text] [Related]
16. Aberrant SENP1-SUMO-Sirt3 Signaling Causes the Disturbances of Mitochondrial Deacetylation and Oxidative Phosphorylation in Prion-Infected Animal and Cell Models.
Chen DD; Shi Q; Liu X; Liang DL; Wu YZ; Fan Q; Xiao K; Chen C; Dong XP
ACS Chem Neurosci; 2023 May; 14(9):1610-1621. PubMed ID: 37092685
[TBL] [Abstract][Full Text] [Related]
17. Selective intra-arterial brain cooling induces cerebral protection against ischemia/reperfusion injury through SENP1-Sirt3 signaling.
Cai H; Bian X; Chen L; Zhang N; Li L; Tang W; Liu X; Li Z
Free Radic Biol Med; 2021 Aug; 171():272-283. PubMed ID: 34019931
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 Facilitates Acute Myeloid Leukemia Chemoresistance via Mitofusin 1-Mediated Mitochondrial Fusion.
Hou D; Zheng X; Cai D; You R; Liu J; Wang X; Liao X; Tan M; Lin L; Wang J; Zhang S; Huang H
Mol Cancer Res; 2023 Dec; 21(12):1366-1378. PubMed ID: 37698549
[TBL] [Abstract][Full Text] [Related]
19. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation.
Hirschey MD; Shimazu T; Goetzman E; Jing E; Schwer B; Lombard DB; Grueter CA; Harris C; Biddinger S; Ilkayeva OR; Stevens RD; Li Y; Saha AK; Ruderman NB; Bain JR; Newgard CB; Farese RV; Alt FW; Kahn CR; Verdin E
Nature; 2010 Mar; 464(7285):121-5. PubMed ID: 20203611
[TBL] [Abstract][Full Text] [Related]
20. HES1 activation suppresses proliferation of leukemia cells in acute myeloid leukemia.
Tian C; Yu Y; Jia Y; Zhu L; Zhang Y
Ann Hematol; 2015 Sep; 94(9):1477-83. PubMed ID: 26092281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
